AI assistant
Sending…
Karo Pharma AB — Major Shareholding Notification 2008
Feb 6, 2008
6166_iss_2008-02-06_5403048e-3368-4101-b584-67a6db367ca0.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Karo Healthcare AB
Holder
Consepio
Instrument
| Instrument | A SE0000571416 |
|---|---|
| Before the transaction | |
| Shares | 5,759,852 |
| Voting rights | 5,759,852 |
| Transaction | |
| Reason for major shareholding notification Buy | |
| Date | 05/02/2008 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 5,834,852 |
| Directly held voting rights | 5,834,852 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.02 % |
| Directly held voting rights | 5.02 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | |||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled | |||
| - Cash settled | |||
| Total | |||
| Published | |||
| 06/02/2008 10:45 | |||
| Contact | |||
| Name | Kjell Bjurefeldt | ||
| Phone | 08 679 88 41 Email [email protected] |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Karo Pharma AB
AGM Information
2022
May 31
Board/Management Information
2022
May 27
AGM Information
2022
May 2
Share Issue/Capital Change
2022
Apr 19
Share Issue/Capital Change
2022
Apr 19
M&A Activity
2022
Apr 1
M&A Activity
2022
Apr 1
Report Publication Announcement
2022
Mar 23
Capital/Financing Update
2022
Mar 23
Capital/Financing Update
2022
Mar 16